How To Profit From Zogenix’s Upcoming Data
Insights - Zogenix (ZGNX) will be releasing data from its pivotal Phase 3 program of ‘ZX008’ intended for the treatment of Dravet Syndrome (DS), a form of … Continue Reading
Read nowSearch Results for zogenix
Zogenix Cuts the Albatross from Around its Neck
Insights - Zogenix (ZGNX) is divesting of its lead FDA-approved product, the painkiller Zohydro, for $100 million ($30 million in cash up front) and almost $300 million in potential milestone payments. As much as the cash and milestone potential are important to Zogenix, which is re-positioning itself as a pipeline story, more important is that Zogenix is cutting loose the albatross around its neck for the last year and a half.
Read now
Some Relief for Investors: Zogenix Says New Painkiller as Early as 2015
Insights - Shares of biopharmaceutical company Zogenix, Inc. (ZGNX) are up 16% in trading on Wednesday after the company announced that a new, abuse-deterrent formulation of Zohydro … Continue Reading
Read now
Zogenix Consolidating Its Product Franchise is Good for Investors
Insights - On Thursday morning, Zogenix, Inc (ZNGX) announced that the co-promotion of SUMAVEL DosePro (sumatriptan injection) with Mallinckrodt (MNK) will end on January 31, 2014. The stock is up 6% as … Continue Reading
Read now
The Long Case for Zogenix
Research - Zogenix (ZGNX) expects to net $56 million from a secondary offering revealed on November 4, $64.4 million with full exercise of the underwriter’s over-allotment option. … Continue Reading
Read nowZogenix Is Having a Hard Time with its Capital Needs
Short Ideas - Zogenix (ZGNX) in a press release Wednesday morning said that it is undertaking cost-control initiatives in order to achieve key business milestones in 2013, including: … Continue Reading
Read nowZogenix Poised for 40% Haircut as Zohydro Decision Approaches
Most Popular - Co-written by Jake King and Rajesh Patel, Ph.D. Zogenix (ZGNX) currently awaits an approval decision from the FDA on Zohydro ER (extended release), a hydrocodone … Continue Reading
Read now